Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials Z Liang, X Chen, J Shi, H Hu, Y Xue, COL Ung Chinese medicine 16, 1-38, 2021 | 20 | 2021 |
National drug utilization trend of analgesics in China: an analysis of procurement data at 793 public hospitals from 2013 to 2018 H Shi, X Chen, X Liu, H Zhu, F Yu, COL Ung, WS Chan, H Hu, S Han Journal of Pharmaceutical Policy and Practice 14 (1), 45, 2021 | 8 | 2021 |
Drug utilization for pain management during perioperative period of total knee arthroplasty in China: a retrospective research using real-world data X Chen, L Yang, X Liu, H Zhu, F Yu, COL Ung, H Hu, W Chan, H Shi, ... Medicina 57 (5), 451, 2021 | 4 | 2021 |
Application of implementation science framework to develop and adopt regulatory science in different national regulatory authorities J Shi, X Chen, H Hu, COL Ung Frontiers in Public Health 11, 1172557, 2023 | 3 | 2023 |
PNS345 business model innovation of internet hospitals in China: A systematic review YF Lai, X Chen, S Chen, Y Huang, H Huang, COL Ung, H Hu Value in Health 22, S822, 2019 | 2 | 2019 |
Is there a role for traditional and complementary medicines in managing chronic fatigue? a systematic review of randomized controlled trials Y Li, J Yang, CI Chau, J Shi, X Chen, H Hu, COL Ung Frontiers in pharmacology 14, 1266803, 2023 | 1 | 2023 |
Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): implications for future drug development and trial design X Chen, J Shi, Y Lai, Y Xue, COL Ung, H Hu Chinese Medicine 18 (1), 58, 2023 | 1 | 2023 |
Benchmarking drug regulatory systems for capacity building: an integrative review of tools, practice, and recommendations J Shi, X Chen, H Hu, COL Ung International Journal of Health Policy and Management 12, 2023 | 1 | 2023 |
Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature Y Xue, H Zou, Z Ruan, X Chen, Y Lai, D Yao, COL Ung, H Hu Frontiers in Endocrinology 14, 1254398, 2023 | | 2023 |
Efficacy and safety of traditional Chinese medicine for cancer-related fatigue: a systematic literature review of randomized controlled trials J Yang, Y Li, CI Chau, J Shi, X Chen, H Hu, COL Ung Chinese Medicine 18 (1), 142, 2023 | | 2023 |
Comparative analysis of disease modelling for health economic evaluations of systemic therapies in advanced hepatocellular carcinoma H Zou, Y Xue, X Chen, Y Lai, D Yao, COL Ung, H Hu Plos one 18 (10), e0292239, 2023 | | 2023 |
推進藥品監管體系和監管能力現代化:藥品監管能力基準評估的國際經驗 吴霭琳时君楠,陈献文, 胡豪, 中国食品药品监管, 14-33, 2023 | | 2023 |
馬來酸麥角新堿注射液臨床使用可及性與處方管理探討 史錄文林芳卉 鄭麗英 王毓豐 陳獻文 張珺懌 韓晟 唐磊 張威 鄧艷萍 中國藥物依賴性雜志 31 (5), 401-406, 2022 | | 2022 |
PDG74 Drug utilization of patients with respiratory disease at community pharmacies in China: an analysis of chemical drugs (2014-2017) YF Lai, SQ Chen, PH Chen, XW Chen, COL Ung, H Hu Value in Health 22, S175, 2019 | | 2019 |
PRS48 Drug utilization of patients with respiratory disease at community pharmacies in China: an analysis of leading prescription and over-the-counter drugs YF Lai, XW Chen, SQ Chen, PH Chen, COL Ung, H Hu Value in Health 22, S358, 2019 | | 2019 |
中國呼吸系統疾病藥物利用現狀:基于3個數據庫比較分析 胡豪賴云鋒 陳獻文 陳圣琦 郭琰 別瑞雪 韓晟 史錄文 中國藥物經濟學 14 (1), 21-25, 2019 | | 2019 |